Monday, June 7, 2021
11:20 AM EST – Aeterna Zentaris Inc. : Has engaged neuroimmunologist, Michael Levy, MD, PhD, Research Director of the Division of Neuroimmunology & Neuroinfectious Disease at Massachusetts General Hospital as a scientific consultant to support the development of the Company’s targeted, highly specific immunosuppressive therapeutic proteins for the potential treatment of neuromyelitis optica spectrum disorder. Dr. Levy will provide scientific support and advice to Aeterna Zentaris in the field of inflammatory CNS disorders, autoimmune diseases of the nervous system, and NMOSD. Aeterna Zentaris Inc. (T.AEZS) shares were up $0.01 at 1.07.
Stocks in Play: Aeterna Zentaris Inc., Mon, 07 Jun 2021 11:27:11 EST